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Hydrogels have garnered much attention over the past few decades for their ability 
to deliver therapeutics with spatial and temporal control. However, many of these systems 
can exhibit burst release and are not easily adjusted to realize different release kinetics. The 
research reported in this thesis aims to develop tunable degradable hydrogels from 
oxanorbornadiene linkers, which have been shown to have programmable fragmentation 
rates that can be tuned over an exceptionally wide range of time. OND hydrogels of 
different crosslinking compositions were all able to form robust gels in as little as seconds 
and release of entrained cargo was found to be tunable over 0.5 to 25 days by changing the 
OND substitution or crosslinking system. Oxanorbornadiene hydrogels were then applied 
to in vivo models seeking to improve healing in chronic wounds where it was found that 
OND hydrogels were able to deliver therapeutic cargo at the expected preprogrammed rates 
to improve wound healing. Degradable hydrogels comprised of OND cleavable linkages 
continue to show great promise as simple drug delivery systems that can be widely useful 










1.1 General Introduction of Hydrogels 
It is well understood that drug potency does not always correlate with therapeutic 
efficacy but is rather largely dependent on the delivery system of the drug.1 Low 
bioavailability, off-target effects, and immunogenicity are all important obstacles to 
efficient delivery.1,2 To address these obstacles, research has focused on the development 
of controlled release delivery systems such as liposomes, nanoparticles, and hydrogels, 
which are able to release therapeutics with temporal and spatial control.   
Hydrogels are water-swollen polymer networks that are able to hold a three-
dimensional shape. Networks can be physically crosslinked by noncovalent interactions or 
chemically crosslinked by water-tolerant reactions such as Michael addition, CuAAC, 
thiol-ene, and Diels-Alder.3 Hydrogel materials are typically biocompatible due to their 
high-water content as well as their stiffness, which can be tuned to match the physical 
properties of different structural tissues.4 Another tunable property of hydrogels is their 
size, which can be cast anywhere from nanometers to centimeters. Nano or micro gels are 
small enough to pass through needles and are thus often used for injectable administration.4 
On the other hand, larger hydrogels are often used for transdermal delivery and have been 
investigated in the treatment of wounds.5 
One of the first hydrogels for a therapeutic application was reported in 1960 by O. 
Wichterle and D. Lím and described the polymerization of glycomonomethacrylate to form 
porous transparent gels for contact lenses.6 Hydrogel delivery systems were reported by 
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Nalbandian, Henry, and Wilks in 1972 where they used a surfactant based gel to suspend 
and deliver bactericidal agents to burn wounds.7 Over the last few decades advancements 
in hydrogel delivery systems have centered largely on tuning mechanical and degradation 
profiles to better control release of cargo.  
1.2 Hydrogel Release Mechanisms 
In order to better control and extend cargo delivery, hydrogels have been 
engineered to have different release mechanisms (Figure 1). Mechanisms that are 
dependent on interactions between the cargo and hydrogel network include electrostatic 
interactions, hydrophobic associations, and cleavable linkages.4 Affinity based delivery 
systems have been used to deliver growth factors such as VEGF from heparin based 
hydrogels over periods of 5 to 7 days.8,9 Release mechanisms based on hydrophobic 
associations, such as cyclodextrin inclusion complexes, have been able to achieve similar 
release kinetics to affinity based delivery systems.10-12 While both mechanisms are able to 
extend delivery of cargo when compared to diffusion mechanisms, they can still exhibit 
burst release kinetics, which is the uncontrolled release of cargo.  
Hydrogels that employ cleavable linkages have been shown to achieve slightly 
longer release timeframes as well as smaller degrees of burst release.4 Cleavage by β-
elimination is one common release mechanism of tethered drugs that has achieved release 











Hydrogels are also able to physically entrain (or “trap”) drug cargo rather than 
tethering it by one or more cleavable bonds. In this case, drug release can be regulated by 
altering the mesh size of the hydrogel network, determined by the distances between 
crosslinks. As the drug or related cargo moves within the gel network it encounters varying 
degrees of steric interactions, which is largely dependent on the mesh size.4 Distances 
between crosslinks that are much larger than the drug allow for uncontrolled release from 
the hydrogel dependent only on the intrinsic diffusion properties of the cargo.  
Although cleavable linkages have traditionally afforded longer half-lives, 
degradable cargo-trapping hydrogel systems offer dynamic control of mesh size and thus 
can achieve systems that can have longer release timeframes with lower burst release.4 










immobilized within the network until degradation of the network allows the drug to move 
through the hydrogel and be released. Hydrogels have been engineered to have many 
different degradation mechanisms, the most common being ester hydrolysis, enzymatic 
hydrolysis, and photolytic cleavage. Photocleavable linkages offer real-time control over 
hydrogel degradation for on-demand release. Such examples can be seen in hydrogels with 
nitrobenzyl moieties which cleave when exposed to 365 nm light.14,15 However, a major 
limitation of these systems is that UV light is not able to penetrate deeply into tissue and 
could also damage healthy cells.16  
Examples of hydrolytic cleavage mechanisms have included hydrogels made from 
poly(ethylene glycol) and poly(lactide) to form gels with degradation rates of 
approximately two weeks.17,18 Hydrogels made from the crosslinking of hyperbranched 
poly(b-amino ester)s with thiolated hyaluronic acid were found to have similar stabilities.19 
Hydrogels with enzymatic cleavage mechanisms can exhibit degradation rates over hours 
or weeks depending on the system and enzyme. For example, hydrogels consisting of 
dextran and collagen-derived peptides were able to release fluorophores over 16 days in 
the presence of matrix metalloproteinases.20 Another example of enzymatic degradation 
can be seen in functionalized hyaluronan gels with hydrazone crosslinks, which were found 
to degrade over 40 to 100 hours in the presence of hyaluronidase at physiological pH.21  
Although these degradation release mechanisms were able to achieve longer release 
timeframes under mild conditions, they were not easily tunable and required adjustment of 
crosslinking density, weight percent, and monomer incorporation among other factors to 
generate different release profiles, making these systems quite complicated. The lack of 
tunable hydrogel systems is problematic considering that many applications require 
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different degradation and release properties. For example, hydrogel scaffolds in tissue 
engineering need to degrade at rates similar to tissue growth whereas injectable depot drug 
delivery systems for the treatment of certain cancers would ideally have long term release 
over 6 or 12 months.22 Consequently, there is a need for hydrogels with highly tunable 
properties, which can be adapted to fit a wide variety of medical applications.  
1.3 Introduction of Oxanorbornadienes 
Oxanorbornadienes (ONDs) are the products of the [4+2] cycloaddition of furans 
with electron-deficient alkynes, and are excellent Michael acceptors toward thiols. Retro-
Diels-Alder fragmentation is triggered by thiol addition, yielding the starting furan and 
thiomaleate (Figure 2).23 Thiol addition occurs rapidly, and the resulting fragmentation is 
tunable on the order of hours to months depending on the furan substitution. Extensive 
studies have been done to explore the rate of this fragmentation process using b-
mercaptoethanol-OND adducts with varying OND substitution at the 1 and 4 positions. For 
example, the addition of a methyl group at the bridgehead carbon of the dimethyl ester 
OND increased the half-life from 12 hours to 51 hours (Figure 2, R2=R3=CO2Me, R1=H 
vs. Me) which could be further increased up to 20 days by the addition of amine derivatives 
at the same location.24 Factors proposed as being important in the control of these rates 
include intramolecular hydrogen bonding (such as between a pendant sulfonamide proton 
and OND ester group24) and the electronic natures and symmetries of the diene and 






Figure 2. OND thiol addition followed by retro-Diels-Alder fragmentation. 
 
 
The tunable nature of OND stability has led to the use of these structures as 
cleavable linkers in drug delivery systems. In one model study, ONDs were explored as 
linkers that could release cargo from serum albumins at rates between half a day and 7 days 
depending on the OND substitution pattern.26 This study, which was done under 
physiological conditions, highlights the utility of ONDs in complex mixtures. Since the 
retro-Diels-Alder rate responds mostly to changes in the molecular structure and not to the 
external conditions, one can have high confidence that performance in vitro will predict in 
vivo results. 
1.4 Oxanorbornadienes as Cleavable Linkers in Degradable Hydrogels 
These properties prompted further investigation of ONDs as cleavable linkages in 
hydrogel delivery systems. In an initial study, divalent ONDs of different substitution were 
reacted with tetravalent PEG-thiols to form 10 wt% hydrogels.27 As predicted, hydrogels 
made with different ONDs exhibited similar characteristics of swelling and pH insensitivity 
while having different, pre-programmed, degradation rates. Furthermore, it was found that 
OND hydrogels were able to release entrained cargo at predictable rates over 6 to 80 hours 





















release rates were dependent on diffusion rather than mesh size.27 A practical drawback of 
this initial system was that the OND small molecule needed to be dissolved in an aqueous 
mixture containing DMSO.  
Oxanorbornadiene reagents have shown great promise as cleavable linkages in 
degradable hydrogel systems due to their programmable fragmentation rates, which can be 
tuned over an exceptionally wide range of time. The unique properties of 
oxanorbornadienes present an opportunity to create broadly effective drug delivery systems 
that can be suitable to a wide range of applications without making the hydrogel 
formulations too complex. The present thesis describes further efforts in the development 
of OND hydrogels to enhance the biocompatibility of the system and to explore 



















Oscillatory rheology data presented in this chapter were obtained by Jonas Cuadrado in 
Dr. Alberto Fernandez-Nieves’ lab at the Georgia Institute of Technology. 
 
2.1 Introduction 
Current hydrogel delivery systems are able to achieve a wide variety of release 
timeframes, but this usually requires significant changes in composition. It would be 
advantageous if the same basic system could be used to make tunable hydrogels that can 
applied to a variety of problems, without added complexity. 
Oxanorbornadiene molecules have been well studied by the Finn lab and were 
shown to undergo retro-Diels-Alder fragmentation after thiol addition with predictable 
rates that varied over an extremely wide time range depending on the OND substitution.23-
27 OND hydrogels have previously been explored where a divalent OND small molecule 
was crosslinked with tetravalent PEG-SH to form degradable hydrogels. OND linkers were 
used to generate hydrogels with two different release mechanisms, one in which the OND 
acted as a cleavable bond in the hydrogel network and the other as a cleavable linkage 
between the network and the cargo. Cleavage of the hydrogel network was shown to be 
able to release cargo over 6 to 80 hours depending on the OND retro-Diels-Alder rate.27 
We elaborated on this delivery system by investigating hydrogels where ONDs are 
coupled onto either dextran or PEG and then crosslinked with PEG or dextran thiols of 
different valency. Dextran is a water-soluble natural polysaccharide that has been shown 
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to have low protein absorption.28 In addition, studies have shown that dextran with 
molecular weights less than 30,000 are able to be excreted through the kidneys.29 The 
incorporation of dextran into the OND hydrogel delivery system was expected to enhance 
biocompatibility by eliminating the need for DMSO. The properties of these new hydrogel 
crosslinking compositions were explored as described in the following section.  
2.2 Results 
2.2.1 Synthesis and fabrication of hydrogels 
Oxanorbornadienes were synthesized via Diels-Alder reaction with a commercially 
available furan and two different substituted alkynes to obtain ONDs with varying 
stabilities (Figure 3). From previously published kinetic studies, it is expected that methyl 
ester OND 2 and CF3 OND 3 will have retro-Diels-Alder half-lives of approximately 18 
and 220 days respectively at 25°C.24 OND 4, the epoxide of OND 2, cannot undergo retro-
Diels Alder fragmentation and thus can be used to generate non-degradable hydrogels for 
comparison.24 ONDs 2-4 were coupled to either dextran (20K) or divalent PEG-amines and 
then reacted with either tetravalent PEG-SH, divalent PEG-SH, or dextran-SH. For each of 
the three ONDs, four different crosslinking systems were investigated as outlined in Figure 
4. The first three crosslinking systems were dextran-OND with tetravalent PEG-SH, 
divalent PEG-SH, and dextran-SH. The last crosslinking system explored was divalent 
PEG-OND with dextran-SH. Experimental details of the synthesis of these materials are 






Figure 3. Selected ONDs to be used as degradable (2 and 3) or non-degradable (4) 




Figure 4. Representation of different hydrogel crosslinking systems that were 
implemented in OND hydrogels. 
 
Gels were prepared by dissolving OND and thiol material separately in 0.001 M 
potassium phosphate buffer to make a 10 wt% solution. The OND and thiol materials were 
then mixed together in a 1-to-1 ratio of thiol to electrophile to form self-supporting 10 wt% 
gels. The point of gelation was recorded as the time the sample ceased to flow by the 
inversion test. At room temperature and physiological pH all gels were fully formed in less 
than 20 seconds.  
=  Dextran =  Tetravalent PEG=  Divalent PEG =  Thiol =  OND  tr   i l  =  Dex an   l  = v t   i l   























The rate of gelation could be altered by changing the buffer salt concentration or 
pH of the solution. Increasing the buffer salt concentration was found to dramatically 
increase gelation speed and lowering the pH of the hydrogel solutions was found to 
decrease gelation speed. For example, at pH 5.5 gels took between 2 and 18 minutes to 
fully form depending on the type of OND and the crosslinking system, with hydrogels 
made from divalent PEG-SH and dextran-OND taking the longest (2.4.3 Figure 13). 
Gelation could also be slowed, typically by 30-60 seconds, by cooling the samples on ice.  
2.2.2 Swelling ratio and gel fraction determination 
 The swelling ratio of a hydrogel describes the weight increase of the hydrogel due 
to water absorption. Swelling ratio has been shown to be linked to the number of crosslinks 
within the hydrogel network: materials with large numbers of crosslinks are expected to 
swell less than materials with fewer crosslinks. If swelling ratios are very large then release 
of entrained and immobilized cargo is less dependent on degradation of the hydrogel 
network and is instead more dependent on diffusion, which is known to give a burst release 
profile.30 Consequently, lower swelling ratios are desirable. The gel fraction of a hydrogel 
describes the degree to which the starting material was incorporated within the hydrogel 
network.  
 Swelling ratios were determined by suspending hydrogels in water and comparing 
the hydrogel mass after 24 hours to the original hydrogel mass. Gel fractions were 
determined by lyophilizing hydrogels and comparing the lyophilized mass to the mass of 
the OND and thiol materials that went into the hydrogel. Further experimental details are 
outlined in sections 2.4.4 and 2.4.5. The results from swelling and gel fraction studies are 
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outlined in Table 1. All gels were made as described in the previous section unless 
otherwise noted.  
 






* 5 wt% gels 
 
When comparing crosslinking systems, the dextran-dextran crosslinking system 
(C) had the lowest swelling ratios and highest gel fractions. Gel fractions for the 4-arm (A) 
and 2-arm (B) crosslinking systems were also fair with the exception of entries 1 and 5, 
which both exhibited very poor gel fractions. It was hypothesized that a sufficient number 
of crosslinks were being formed to make robust hydrogels with only half of the starting 
material and that very fast gelation could result in the exclusion of excess material from 
Entry CrosslinkingSystem OND Swelling Ratio Gel Fraction
1 A 2 2.2 0.42
2* A 2 1.2 0.98
3 A 3 3.0 0.84
4 A 4 1.1 0.90
5 B 2 2.6 0.50
6* B 2 1.5 0.98
7 B 3 2.0 0.72
8 B 4 2.1 0.78
9 C 2 1.4 0.96
10 C 3 1.8 0.92
11 C 4 1.2 0.82
12 D 2 1.7 0.4
13 D 3 3.5 0.86
14 D 4 1.7 0.62
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the bulk hydrogel network. When the experiment was repeated with 5 wt% gels rather than 
10 wt% almost all of the material was able to be incorporated within the hydrogel network.  
Among ONDs 2, 3, and 4, materials made with OND 3 consistently exhibited the 
largest swelling ratios. This can be attributed to the lower degree of substitution of OND 3 
on dextran (15%) which would result in fewer crosslinks when compared to ONDs 2 and 
4 which had 20% and 25% substitution respectively.  
2.2.3 Oscillatory rheology 
 We characterized three different hydrogels by oscillatory rheology in order to 
investigate how differences in crosslinking might affect their strength and aging properties. 
The three selected gels were made with methyl ester OND 2 and had the following 
crosslinking systems: OND-dextran and tetravalent PEG-SH (2A), OND-dextran and 
dextran-SH (2C), and OND-PEG and dextran-SH (2D). Oscillatory rheology in the linear 
regime showed that the storage modulus (G’), which describes the elastic behavior of the 
sample, initially started below the loss modulus (G’’),  which describes the viscous 
behavior of the sample, and quickly increased well above G’’ until G’’ was negligible in 
comparison. The point where G’ crosses over G’’ is indicative of gelation and once G’ 
stabilizes the hydrogel is fully formed. The solid-like nature of the selected hydrogels was 
further confirmed by observing that G’ was much greater than G’’ at all frequencies and 
was found to be independent or only weakly dependent on oscillatory frequency (2.4.6 
Figure 14).  
 Storage and loss moduli measurements were continued until G’ started to or 
completely crossed back below G’’ at which point the hydrogel had degraded and was no 
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longer solid-like. As seen in Figure 5, the OND-dextran and tetravalent PEG-SH gel (2A) 
reached a maximum storage modulus of 20 kPa and degraded after approximately 11.5 
days. The OND-dextran and divalent PEG-SH gel (2C) reached a maximum storage 
modulus of 3 kPa and degraded after approximately 11.5 days and the OND-PEG and 
dextran-SH gel (2D) reached a maximum storage modulus of  1 kPa and degraded after 2.3 
days.  Gels 2A and 2C both had long aging times where degradation didn’t occur until 11.5 
days. Gel 2A had a much larger storage modulus when compared to gel 2B which can be 
attributed to larger degrees of crosslinking. The OND-PEG gel (2D) had the shortest aging 
time and the smallest maximum storage modulus. The small storage modulus can be 
attributed to smaller degrees of crosslinking which aligns with the data from the swelling 






Figure 5. (A) Oscillatory strain sweep of Hydrogel 2D at an angular frequency of 1 rad/s. 
(B) Time dependence of G’ and G’’ for Hydrogel 2A at a constant strain of 25% and an 
angular frequency of 1 rad/s. (C) Time dependence of G’ and G’’ for Hydrogel 2C at a 
constant strain of 25% and an angular frequency of 1 rad/s. (D) Time dependence of G’ 




2.2.4 Release studies of entrained Qβ virus-like-particles 
 Oxanorbornadiene hydrogel delivery systems can deliver cargo through two 
different strategies, both of which rely on the retro-Diels Alder fragmentation of the OND. 
The first involves the OND acting as a cleavable linkage between cargo and the hydrogel 
network while the second implements the OND as a cleavable linkage between the 






































































hydrogel network itself. The second controlled release strategy is dependent on the size of 
the cargo in relation to the mesh size of the hydrogel network. If the cargo is much smaller 
than the hydrogel mesh size then release will be entirely dependent on diffusion, which is 
known to exhibit burst release kinetics.3, 30 In order to prevent burst release, the entrained 
cargo must be large enough to be essentially immobilized within the hydrogel network 
until the network begins to degrade, thus allowing the cargo to move. Qβ virus-like-
particles were chosen as a model cargo candidate because of their large size (nearly 30 nm 
wide) as well as their ability to easily package fluorescent proteins. To examine the release 
profiles of hydrogels with different ONDs and crosslinking systems, Qβ VLPs were 
entrained within hydrogels, and release was monitored by fluorescence of the supernatant. 
Further experimental details are outlined in section 2.4.7.  
 Release of entrained Qβ cargo from methyl ester OND hydrogels took between 12 
and 66 hours depending on the type of crosslinking system (Figure 6). Hydrogel system 
2D (OND-PEG and dextran-SH) took only 12 hours to release 100 percent of entrained 
cargo, the least amount of time among the four different methyl ester OND hydrogels. 
While hydrogel 2D displayed release kinetics similar to burst release, hydrogels 2B (OND-
dextran and divalent PEG-SH) and 2C (OND-dextran and dextran-SH) had much more 
linear release curves and took 30 and 42 hours respectively to release 100 percent of 
entrained Qβ cargo. Hydrogel 2A (OND-dextran and tetravalent PEG-SH) had the longest 
release timeline and took 66 hours to release the Qβ-RFP cargo. Although hydrogel 2A had 
the longest release profile out of the four different crosslinking systems, the release curve 
was not linear and instead went through an induction period where there was minimal cargo 
release for the first 36 hours followed by close to linear release over the next 30 hours. 
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Since hydrogel 2A has a high degree of crosslinking, as demonstrated by swelling and 
oscillatory rheology studies, it is likely that more OND linkages have to break in order for 
the Qβ cargo to be able to move around within the hydrogel network, which would result 





Figure 6. Release of entrained Qb virus-like particles packaged with RFP from methyl 




Release of entrained Qβ cargo from CF3 OND hydrogels took between 160 and 600 
hours or 6.7 days and 25 days depending on the crosslinking system (Figure 7). Hydrogel 
3B had near linear release kinetics over almost one week, which was the shortest release 






















timeline of the four different CF3 gels. Hydrogel 3D also had near linear release kinetics 
over 11.5 days while hydrogels 3A and 3B had non-linear release kinetics. Hydrogel 3A 
went through a similar induction period as seen in the methyl ester OND release study and 
took almost 18 days to release all of the entrained Qβ cargo. Hydrogel 3C had the longest 
release timeline out of any of the gels with 25 days being needed to completely release all 
cargo, however, release rates were not consistent and exhibited a similar induction period 
as seen with the 4 arm crosslinking system. In addition, it was observed that the relative 
degradation rates of 3B and 3D hydrogels were switched in comparison to the degradation 
rates of 2B and 2D hydrogels. This change can be attributed to differences in the degree of 
crosslinking of hydrogel samples 2B and 3B. While the degree of crosslinking in hydrogels 
2D and 3D can be assumed to be the same, hydrogel 3B had a slightly lower degree of 
crosslinking than 2B due to differences in OND substitution on dextran (15% and 20% 
respectively). The reduced substitution of OND 3 in hydrogel 3B most likely resulted in 







Figure 7. Release of entrained Qb virus-like particles packaged with RFP from CF3 OND 




 In order to validate that the release of Qβ VLPs from OND hydrogel systems was 
a function of the retro-Diels Alder fragmentation of selected ONDs rather than diffusion 
or hydrolysis of ester linkages, release experiments were carried out with epoxide ONDs. 
As stated earlier, epoxide ONDs are not able to undergo cycloreversion and thus can be 
used to form stable hydrogels that will not degrade by OND cleavage.24 Consequently, 
encapsulated Qβ VLPs within epoxide OND hydrogels are not expected to be released. As 
shown in Figure 8, release of Qβ VLPs from epoxide OND hydrogels with crosslinking 
systems A-D was stabilized at around 15-25% for over 2 weeks. The initial release of Qβ 
VLPs seen at the beginning of the experiment is interpreted to be the shedding of VLPs 
stuck on the surface of the hydrogel rather than VLPs that are encapsulated within the gel. 
This observation is consistent with the results from the two aforementioned release studies 






















with methyl ester and CF3 OND hydrogels. Since there was no detectable release of VLPs 
from epoxide gels after the initial shedding it can be assumed that release of entrained cargo 
from the previously mentioned studies was dependent on the cleavage rate of OND linkers.   
 
 
Figure 8. Release of entrained Qb virus-like particles packaged with RFP from non-




This work expands the scope of  controlled OND hydrogel delivery systems in 
which a nucleophilic thiol adds to an oxanorbornadiene Michael acceptor rapidly to form 
network linkages that will undergo tunable retro-Diels-Alder fragmentation.  






















A library of OND hydrogels with linkages of varying stabilities were synthesized 
and their release patterns of encapsulated cargo explored. OND hydrogels took only 
seconds to form robust gels with high material incorporation and low swelling ratios. 
Release studies of entrained Qβ virus-like-particles packaged with red fluorescent protein 
demonstrated the tunability of this delivery system where release of cargo was programmed 
to take as little as 12 hours or as long as 3.5 weeks depending on the OND and crosslinking 
system. While some crosslinking systems displayed an induction-period followed by 
steady release, other systems experienced near linear release, which is ideal for hydrogel 
delivery systems. 
Collectively, readily tunable OND hydrogels were achieved through simple 
alterations of the OND substitution or crosslinking system, which allows them to be 
broadly useful in a variety of applications, one of which will be discussed in the next 
chapter. 
2.4 Experimental 
2.4.1 General information 
Reagents and solvents were purchased from commercial sources and used without 
further purification unless otherwise stated. Water was purified on a Millipore Milli-Q 
Advantage A10 system. Dextran (20K) was purchased from Alfa Aesar and was dried with 
toluene prior to use. Divalent and tetravalent PEG-thiols were purchased from JenKem 
Technologies, USA and were stored in a nitrogen purged glove box. Thiol content was 
periodically assessed through Ellman’s Assay and starting thiol content was found to be 
95%. The reactions took place under ambient conditions without any attempt to exclude 
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air other than capping of the reaction vessel. Flash column chromatography was performed 
on the Biotage® Automated Liquid Chromatography System Isolera 
One® using Biotage® SNAP KP-Sil 10 g silica gel cartridges. Analytical thin layer 
chromatography (TLC) was performed using Whatman glass plates coated with 0.25 mm 
silica gel and were visualized with UV light and/or potassium permanganate stain. Dye 
containing compounds were protected from light by aluminum foil. 
NMR spectra were obtained using Brüker AMX-400 and DRX-500 instruments in 
deuterated solvents (Cambridge Isotope Laboratories, Inc.) and were referenced to the 
solvent. Spectra were processed in MestreNova software (Mestrelab Research). High-
resolution mass spectrometry was performed on an Agilent 6230 ESI-TOF LC/MS 
instrument (G6230B) operating at 4 GHz with internal reference. LC was performed on an 
Agilent 1260 HPLC with a mobile phase gradient from 0-90% acetonitrile/water containing 
0.1% formic acid on a Zorbax Extend-C18 Rapid Resolution HT (2.1 x 50mm, 1.8µm). 
Absorbance and fluorescence spectra were collected on a VarioskanFlash plate reader 
(ThermoFisher). Oscillatory rheology measurements were obtained on an Anton Paar 
Physica MCR 502 rheometer, equipped with an evaporation blocker hood. Measurements 
were taken using cone-plate geometry and gels were prepared in situ with trimming of any 
excess gel prior to taking measurements. 
Synthetic procedures for compounds 1, 2, 3, and 4 were adapted from previously 
reported procedures.24,27  Dextran-SH was synthesized according to literature and the 
spectroscopic data matched reported values.31   




Figure 9. Synthesis of glutaroyl-furfurylamine. 
 
 
Glutaroyl-furfurylamine: A solution of glutaric anhydride (4g, 35 mmol, 1.7 equiv) in 
dry DCM (25 mL) was slowly added to a solution of furfurylamine (2g, 20.6 mmol) in dry 
DCM (20 mL). The resulting solution was stirred for 4 hours at room temperature. The 
product was filtered, washed with cold DCM, and dried under vacuum (2.9 g, 67% yield). 
1H NMR (400 MHz, Methanol-d4) δ 7.43 (dd, J = 1.9, 0.9 Hz, 1H), 6.35 (dd, J = 3.3, 1.9 
Hz, 1H), 6.25 (dd, J = 3.3, 0.9 Hz, 1H), 4.36 (s, 2H), 2.34 (t, J = 7.4 Hz, 2H), 2.28 (t, J = 
7.5 Hz, 2H), 1.95 – 1.85 (m, 2H). 13C NMR (101 MHz, MeOD) δ 175.36, 173.75, 151.70, 
141.86, 109.92, 106.61, 35.70, 34.54, 32.62, 20.81. HRMS (ESI-TOF) C10H13NO4 [M + 







yl)methyl)amino)-5-oxopentanoic acid: Glutaroyl furfurylamine 1 (1.5 g, 7.1 mmol, 1 
O NH2
























equiv) and dimethyl acetylenedicarboxylate (1.51 g, 10.65 mmol, 1.5 equiv) were 
combined with 1 mL methanol and stirred at 65°C for 20 hours. The resulting solution was 
triturated against ethyl ether to yield a pale yellow precipitate, filtered, and dried under 
vacuum (1.9 g, 76% yield). 1H NMR (400 MHz, Chloroform-d) δ 7.23 (dd, J = 5.3, 1.9 
Hz, 1H), 7.02 (d, J = 5.3 Hz, 1H), 6.23 (s, 1H), 5.66 (d, J = 1.9 Hz, 1H), 4.18 (dd, J = 14.8, 
6.3 Hz, 1H), 4.03 (dd, J = 14.8, 5.3 Hz, 1H), 3.82 (d, J = 14.6 Hz, 6H), 2.41 (t, J = 7.1 Hz, 
2H), 2.30 (t, J = 7.4 Hz, 2H), 1.97 (q, J = 7.2 Hz, 2H). 13C NMR (101 MHz, CDCl3) δ 
177.27, 172.72, 163.90, 162.59, 153.43, 152.91, 145.31, 142.91, 96.90, 83.68, 52.64, 




Figure 11. Synthesis of CF3 OND linker. 
 
5-(((2-(ethoxycarbonyl)-3-(trifluoromethyl)-7-oxabicyclo[2.2.1]hepta-2,5-dien-1-
yl)methyl)amino)-5-oxopentanoic acid: Glutaroyl furfurylamine 1 (1.0 g, 4.7mmol, 1 
equiv) and ethyl 4,4,4-trifluoro-2-butynoate (1.18 g, 7.1 mmol, 1.5 equiv) were combined 
PhMe
EtO2C CF3
















with 1 mL methanol and stirred at 65°C for 24 hours. The resulting solution was 
concentrated and triturated against ethyl ether. The off white solid was filtered and dried 
under vacuum (675 mg, 38% yield). 1H NMR (400 MHz, Chloroform-d) δ 7.21 (dd, J = 
5.3, 1.9 Hz, 1H), 7.09 (dd, J = 5.3, 1.7 Hz, 1H), 5.98 (s, 1H), 5.60 (d, J = 1.9 Hz, 1H), 4.36 
– 4.22 (m, 2H), 4.22 – 4.04 (m, 2H), 2.46 – 2.35 (m, 2H), 2.35 – 2.21 (m, 2H), 2.04 – 1.89 
(m, 2H), 1.33 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 176.66, 173.60, 172.55, 
172.27, 162.21, 151.78, 151.41, 150.77, 144.59, 143.52, 122.71, 120.03, 96.88, 82.57, 
62.16, 62.12, 51.61, 37.66, 37.63, 35.24, 35.06, 32.94, 32.82, 20.75, 20.60, 13.83. HRMS 
(ESI-TOF) C16H18F3NO6 [M + H+] calcd, 378.1164, found 378.1101. 
 
 
Figure 12. Synthesis of Epoxide OND linker. 
 
5-(((6,7-bis(methoxycarbonyl)-3,8-dioxatricyclo[3.2.1.02,4]oct-6-en-1-
yl)methyl)amino)-5-oxopentanoic acid: meta-Chloroperoxybenzoic acid (335 mg, 1.36 
mmol, 1.2 equiv) was added to a solution of OND 1 (400 mg, 1.13 mmol, 1 equiv) in 12 




















flash chromatography on silica gel with a gradient of ethyl acetate through 20% 
MeOH/EtOAc to yield a white solid (45 mg, 11% yield). 1H NMR (400 MHz, Chloroform-
d) δ 6.08 (s, 1H), 5.13 (s, 1H), 4.05 (d, J = 5.8 Hz, 2H), 3.86 (d, J = 16.4 Hz, 6H), 3.83 – 
3.74 (m, 2H), 2.45 (t, J = 7.0 Hz, 2H), 2.36 – 2.29 (m, 2H), 2.04 – 1.96 (m, 2H). 13C NMR 
(101 MHz, CDCl3) δ 177.07, 172.77, 162.89, 161.82, 149.50, 146.83, 91.15, 78.34, 57.14, 
56.43, 52.96, 52.73, 37.02, 34.95, 32.82, 20.50. HRMS (ESI-TOF) C16H19NO9 [M + H+] 
calcd 370.1138, found 370.1101. 
 
General procedure A: OND-Dextran coupling: 
Dextran 20K (334 mg, 2.0 mmol, 1 equiv) and lithium chloride (600 mg, 14 mmol, equiv) 
were added to 30 mL DMF and stirred at 90°C for 30 minutes. The resulting solution was 
cooled to 0°C and N,N’Dicyclohexylcarbodiimide (518 mg, 2.5mmol, 1.25 equiv), OND 
2, 3, or 4 (0.4 equiv), and 4-(dimethylamino)pyridinium 4-toluenesulfonate (77.5 mg, 0.27 
mmol, 0.14 equiv) were added to the cooled solution under stirring. The resulting solution 
was stirred at 4°C for 3 days, after which the solution was filtered through a 0.2 µm syringe 
filter and subsequently precipitated in 150 mL acetone under stirring. The white precipitate 
was collected by vacuum filtration, rehydrated in 9 mL water, and dialyzed (MW cutoff 
3500 Da) against water for 2 days at 4°C. The solution was filtered, frozen, and lyophilized 




ME OND DEX: Synthesized according to General Procedure A. 
Experimental substitution 18-25%. 1H NMR (400 MHz, 
Deuterium Oxide) δ 7.42 – 7.32 (m, 1H), 7.18 (d, J = 5.2 Hz, 
1H), 5.87 – 5.74 (m, 1H), 5.18 (s, 1H), 5.01 (d, J = 4.5 Hz, 3H), 
4.32 (s, 2H), 4.08 – 3.92 (m, 7H), 3.86 (d, J = 14.5 Hz, 6H), 3.68 
– 3.49 (m, 7H), 2.52 (s, 2H), 2.34 (s, 2H), 1.93 (s, 2H). 13C NMR 
(126 MHz, D2O) δ 174.29, 165.05, 163.65, 153.61, 153.06, 145.15, 142.15, 97.46, 96.84, 
83.45, 73.15, 71.16, 69.94, 69.26, 65.26, 52.89, 52.73, 37.13, 34.23, 32.85, 32.58, 20.48. 
 
CF3 OND DEX: Synthesized according to General Procedure 
A. Experimental substitution 15%. 1H NMR (400 MHz, 
Deuterium Oxide) δ 7.41 (s, 1H), 7.24 (s, 1H), 6.41 (d, J = 43.4 
Hz, 1H), 5.89 (s, 1H), 5.01 (d, J = 3.8 Hz, 11H), 4.46 – 4.20 (m, 
4H), 4.07 – 3.88 (m, 21H), 3.82 – 3.70 (m, 21H), 3.64 – 3.51 (m, 
18H), 2.52 (s, 2H), 2.34 (s, 2H), 1.93 (s, 2H), 1.34 (d, J = 7.0 
Hz, 3H). 13C NMR (126 MHz, D2O) δ 175.66, 144.80, 142.48, 97.45, 97.00, 82.32, 73.14, 





























































Epoxide OND DEX: Synthesized according to General 
Procedure A. Experimental substitution 25%. 1H NMR (500 
MHz, Deuterium Oxide) δ 5.48 (s, 1H), 5.35 (s, 1H), 5.18 (d, J 
= 4.7 Hz, 3H), 4.37 (s, 1H), 4.30 (s, 1H), 4.25 – 4.10 (m, 7H), 
4.09 – 4.04 (m, 6H), 4.00 – 3.88 (m, 7H), 3.82 – 3.68 (m, 5H), 
3.18 (dd, J = 19.0, 2.9 Hz, 1H), 2.70 (d, J = 7.4 Hz, 2H), 2.53 
(t, J = 7.2 Hz, 2H), 2.16 – 2.06 (m, 2H). 13C NMR (126 MHz, D2O) δ 174.57, 164.23, 
163.16, 148.77, 148.04, 97.77, 91.18, 78.34, 73.44, 71.45, 70.24, 69.63, 65.69, 57.60, 
56.68, 53.35, 53.20, 36.58, 34.49, 33.01, 32.88, 20.64. 
 
General Procedure B: OND-PEG Coupling 
OND 2, 3, or 4 (2.5 equiv.) was dissolved in 1.5 mL of DMF. HATU (52 mg, 0.14 mmol, 
3 equiv) and N,N-Diisopropylethylamine (29.2 mg, 0.23 mmol, 5 equiv.) were added to 
the OND solution followed by addition of PEG(Amine)2, HCl Salt (225 mg, 0.045 mmol, 
1 equiv). The reaction was stirred at room temperature for 2-4 hours followed by 
precipitation in ether. The off-white solid was collected by vacuum filtration, rehydrated 
in 1 mL of water, and dialyzed (MW cutoff 3500 Da) against water for 2 days. The retentate 


































ME OND PEG: Synthesized according to General 
Procedure B. 1H NMR (400 MHz, Deuterium 
Oxide) δ 7.39 (dd, J = 5.3, 2.1 Hz, 2H), 7.18 (d, J = 5.3 Hz, 2H), 5.84 (d, J = 2.0 Hz, 2H), 
4.34 (d, J = 15.2 Hz, 4H), 3.86 (d, J = 13.0 Hz, 12H), 3.73 (s, 605H), 3.65 (t, J = 5.4 Hz, 
6H), 3.56 (d, J = 4.5 Hz, 2H), 3.42 (t, J = 5.4 Hz, 4H), 2.29 (t, J = 7.5 Hz, 8H), 1.93 – 1.85 
(m, 4H). 13C NMR (126 MHz, D2O) δ 175.55, 175.46, 165.12, 163.67, 153.58, 153.13, 
145.13, 142.09, 96.89, 83.44, 69.42, 69.36, 69.27, 69.17, 68.58, 52.85, 52.69, 38.67, 37.07, 




CF3 OND PEG: Synthesized according to 
General Procedure B. 1H NMR (500 MHz, 
Deuterium Oxide) δ 7.39 (dd, J = 5.3, 2.1 Hz, 2H), 7.22 (d, J = 5.3 Hz, 2H), 5.86 (d, J = 
2.0 Hz, 2H), 4.39 – 4.26 (m, 8H), 3.84 (t, J = 2.4 Hz, 4H), 3.71 (s, 701H), 3.62 (t, J = 5.4 
Hz, 6H), 3.57 – 3.55 (m, 2H), 3.39 (t, J = 5.3 Hz, 4H), 2.26 (dt, J = 7.6, 3.9 Hz, 8H), 1.88 
– 1.84 (m, 4H), 1.31 (d, J = 7.2 Hz, 6H). 13C NMR (126 MHz, D2O) δ 175.51, 175.46, 
163.68, 151.26, 150.46, 144.80, 142.49, 97.05, 82.31, 69.41, 69.35, 69.17, 68.58, 63.04, 







































Epoxide OND PEG: Synthesized according to 
General Procedure B. 1H NMR (500 MHz, 
Deuterium Oxide) δ 5.29 (s, 2H), 4.21 (d, J = 15.3 Hz, 2H), 4.07 (dd, J = 34.1, 3.7 Hz, 4H), 
3.87 (s, 6H), 3.84 (s, 6H), 3.83 (d, J = 2.5 Hz, 4H), 3.71 (s, 823H), 3.62 (d, J = 5.3 Hz, 6H), 
3.56 (dd, J = 4.2, 2.0 Hz, 4H), 3.38 (d, J = 5.4 Hz, 4H), 2.28 – 2.25 (m, 8H), 1.86 (s, 4H). 
13C NMR (126 MHz, D2O) δ 175.58, 175.52, 164.06, 162.89, 148.59, 147.87, 91.01, 78.09, 
69.41, 69.35, 69.27, 69.17, 68.57, 57.44, 56.42, 53.05, 52.88, 38.67, 36.27, 34.53, 34.31, 
21.47. 
 
2.4.3 General hydrogel preparation 
Hydrogels were prepared by first dissolving the OND material and thiol material 
separately in 0.001 M potassium phosphate buffer and then combining the two solutions in 
a 1:1 ratio of OND to thiol. Gelation was determined to be complete by the inversion test 
when the gel material was observed to be no longer flowing. Once the OND and thiol 
solutions were mixed, the hydrogels were formed in as little as 2 seconds. Gelation times 
could be tuned as a function of pH or buffer concentration. It was found that increasing the 
buffer concentration sped up gelation significantly and that decreasing the buffer pH could 
slow down gelation. Hydrogels prepared in 7 to 8 pH buffers all took less than 20 seconds 
to gel, whereas most hydrogels prepared in buffers at pH 5.5-7 were still able to form gels 
but took as long as 18 minutes to form self-supporting gels. Gels reported were prepared 
as 10 wt% gels in 0.001 M potassium phosphate buffer, however, gelation could be 



























2.4.4 Determination of swelling ratio 
50 µL 10 wt% gels were prepared in 0.001 M potassium phosphate buffer in a 1:1 
ratio of OND to thiol as described above. The gels were allowed to cure for 5 minutes at 
room temperature, weighed (M0), and then suspended in 1 mL of DI water. The gels were 
stored at 4 °C to prevent significant degradation of the hydrogel network. Hydrogel 
swelling was monitored periodically by decanting, gently wiping any excess water off of 
the gel, and weighing. After 24 hours, when swelling had reached equilibrium, the masses 







































 2.4.5 Determination of gel fraction 
Once the equilibrium mass swelling ratio was determined, the gels were frozen, 
lyophilized and weighed (Mres). The ratio of the residual gel mass to the mass of OND and 
thiol materials that went into making the gel (Min), provided the fraction of gel material 
that was incorporated within the gel network. Any salts present in the gel were expected to 
be removed through exchanging the swelling solvent (DI water).  
𝐺𝑒𝑙	𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = 	6=7>
6?@
                                                     (2) 
2.4.6 Oscillatory rheology 
The viscoelastic properties of different Dextran-OND and PEG-OND gels were 
assessed using oscillatory rheology. 100 µL 10 wt% gels were prepared in 0.001 M 
potassium phosphate buffer in a 1:1 ratio. The solution was quickly mixed and then 
dispensed onto the center of the rheometer plate. The cone was brought into contact with 
the gel and any excess gel was trimmed. The storage (G’) and loss (G’’) moduli were then 
measured overtime at a constant strain of 25% and an angular frequency of 1 rad/s to 
monitor the aging of the gels. It was found that gel samples had a linear response at a wide 
range of strains as seen in Figure 5A. Frequency sweeps in this linear region for the 
different gels showed that there was only a weak frequency dependence as seen in Figure 
14. All gel samples exhibited a sharp increase of G’ over G’’ indicating gelation. G’ 
continued to increase until G’’ was negligible in comparison. This combined with strain 
and frequency sweeps confirmed the solid-like nature of the gel. Storage and loss moduli 
measurements were continued until G’ crossed back to below G’’ indicating that the gel 




























































2.4.7 Release of entrained cargo 
Qb virus-like-particles were prepared by Dr. Soumen Das in the Finn lab. To make 
100 µL 10 wt% gels, separate vials of OND and thiol material were dissolved in a 5.5 
mg/ml solution of Qb virus-like-particles in 0.001 M potassium phosphate buffer. The 
OND and thiol solutions were put on ice for 1 minute. The thiol solution was added to the 
OND solution, the mixture was pipetted up and down and then transferred to molds. The 
gels were allowed to cure for 5 minutes and then were removed from their molds, 
transferred to vials, and suspended in 800 µL of deionized water. The gels were incubated 
at 37°C and release of RFP packaged QB in the supernatant was monitored by fluorescence 
with excitation and emission at 585 nm and 605 nm respectively. All four crosslink systems 
for each type of OND were tested and methyl ester OND and CF3 OND systems were done 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The data presented in this chapter was obtained in experiments carried out by Margarete 
Daisy Johnson in Dr. Wendy L. Havran’s lab at The Scripps Research Institute. All 
fluorescence images and graphs were provided by Daisy Johnson.  
 
3.1 Introduction 
The tunability of oxanorbornadiene hydrogels has been well explored. Simple 
changes to the OND substitution or crosslinking system yield hydrogels with predictable 
degradation rates, between hours or months, making them suitable for many therapeutic 
applications. Here we demonstrate their use in the treatment of chronic wounds.  
Chronic wounds affect over 5 million people annually with a significant portion 
being the elderly population.32 There are a multitude of different factors that lead to non-
healing wounds including cellular changes associated with aging.33,34 Studies from Dr. 
Havran’s lab have shown that γδ T cells play an important role in wound reepithelialization 
but are unresponsive and thus unable to promote wound healing in patients with chronic 
wounds.35 The binding of junction adhesion molecule like protein (JAML) to coxsackie 
and adenovirus receptor (CAR) provides costimulation to dendritic epidermal T cells 
leading to cellular proliferation and cytokine growth. Inhibition of JAML-CAR binding 
has been shown to lead to decreased dendritic epidermal T cell activation and significant 
delays in wound healing, similar to what was observed in the absence of γδ T cells.36 Thus, 
the binding of JAML to CAR could possibly increase the effectiveness of γδ T cells in 
chronic wounds to improve wound healing.  
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Another protein of interest for the treatment of wounds is intercellular adhesion 
molecule-1 (ICAM-1). ICAM-1 plays an important role in the inflammatory response and 
it has been shown that lack of expression of the protein leads to significant delays in wound 
healing, which is commonly seen in aged patients.37 
The controlled local release of these immune modulating agents directly into wound 
beds is of important interest for the treatment of chronic wounds. OND hydrogels have 
been shown to have highly tunable and programable release properties making them 
suitable for topical wound healing applications. The OND hydrogel delivery of CAR-Fc to 
CAR null mice as well as the delivery of ICAM-1-Fc to ICAM-1 null and aged mice were 
investigated and the resulting effects on wound healing are reported.  
3.2 Results 
3.2.1 Selection of hydrogel material 
In order to model the timeline of CAR expression and subsequent dendritic 
epidermal T cell stimulation seen with normal wound healing, hydrogels should 
preferentially be able to release all cargo within 24 hours so the entrained protein can reach 
surrounding wound tissue in a timely manner.36 Due to their short release timelines methyl 
ester OND hydrogels 2B (OND-dextran and divalent PEG-SH, 30 hours) and 2D (OND-
PEG and dextran-SH, 12 hours) were selected for further investigation. In order to validate 
the release timeline of selected OND hydrogels in vivo, reduced Texas Red labeled BSA 
was encapsulated within hydrogels, the hydrogels were applied to 2 mm wounds on mice, 
and release of the labeled BSA into surrounding tissue was monitored by fluorescence at 
different timepoints. BSA was chosen as a model cargo due to its molecular weight, which 
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is close to that of CAR. The first hydrogel that was investigated was hydrogel 2B (10 wt%) 
and the results can be seen in Figure 15. At 24 hours the hydrogels were able to retain dye 
labeled BSA much better when compared to BSA that was delivered just in buffer, however 
the hydrogels were not yet fully degraded. At 37 hours the hydrogels were fully degraded 
and BSA could be seen entering surrounding tissue, however this would miss the 
therapeutic window for delivery of CAR. In an effort to shorten the release timeline, the 
same hydrogel system was repeated with 3 wt% gels rather than 10 wt%. However, there 
were no dramatic differences in fluorescence images when compared to the 10 wt% release 
experiment seen in Figure 15. Consequently, crosslinking system 2B was abandoned for 
this particular application in favor of crosslinking system 2D, which had the shortest 
release timeline seen in previously mentioned release studies. At 5 and 8 hours hydrogel 
2D was still intact and was able to retain the BSA Cargo within the wound bed much better 
than BSA that was delivered in buffer (Figure 16). At 16 hours the gels were almost fully 
degraded, and dye labeled BSA was beginning to enter surrounding tissue. By 24 hours the 
gels were fully degraded and BSA-TxRed was no longer in the wound bed. The in vivo 
release timeline of hydrogel 2D was short enough for entrained cargo to reach surrounding 
wound tissue in a timely manner and was thus selected for future OND hydrogel delivery 
to model chronic wounds. In addition, cell viability studies showed that hydrogel 2D was 






Figure 15. Fluorescent microscopy images of mouse wound beds collected at different 
times. Mice were given either BSA-TxRed in hydrogel 2B or in buffer. The blue color is 





Figure 16. Fluorescent microscopy images of mouse wound beds collected at different 
times. Mice were given either BSA-TxRed in hydrogel 2D or in buffer. White dashed lines 
are outlines of the wound bed, the blue color is DAPI stain, and the red color is BSA-
TxRed. 
 














3.2.2 Delivery of CAR-Fc 
Delivery of Texas Red labeled CAR from hydrogel 2D to mice wounds was 
monitored by fluorescence and compared to results from the BSA-TxRed release studies. 
In order to conserve material, CAR-Fc was not reduced due to the belief that a free thiol 
might already be present, and that the protein is large enough to be entrained within the 
hydrogel network. Fluorescence images collected at 5 and 24 hours showed very similar 
results when compared to the BSA release study where the labeled CAR delivered in the 
OND hydrogel was completely retained within the wound bed at 5 hours and had much 
better retention when compared to labeled CAR delivered in buffer (Figure 17). At 24 hours 
the hydrogels were completely degraded, labeled CAR was no longer in the wound bed 
and instead could be detected in surrounding tissue. Since the release timeline of unreduced 
CAR-Fc matched the release profile of reduced BSA, release studies with CAR-Fc were 
carried out with unreduced protein. 
 
Figure 17. Fluorescent microscopy images of mouse wound beds collected at different 
times. Mice were given either CAR-TxRed in hydrogel 2D or in buffer. White dashed lines 
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In order to assess the effectiveness of CAR-Fc delivery from OND hydrogels to 
chronic wounds, hydrogels were applied to CAR null mice and the rate of wound closure 
was monitored. Results of hydrogel delivery of CAR-Fc to CAR null mice were compared 
against the following groups: wildtype mice that were treated with empty hydrogels (no 
CAR-Fc) and knockout mice that were treated with buffer. As seen in Figure 18 the 
effectiveness of OND hydrogel delivery of CAR-Fc to treat model chronic wounds is not 
initially clear due to the poor separation between wildtype and knockout mice that were 
treated with buffer. This poor separation is a result of different healing kinetics in the 
wildtype mice than what is normally seen, which is most likely caused by the bandages 
that are wrapped around the mice to prevent them from attempting to remove the hydrogels. 
Since the bandages are essential to maintaining the integrity of the hydrogel throughout 
wound healing experiments, other wounding strategies were investigated to improve the 
baseline separation between the knockout and wildtype mice. Increasing the size of the 
wounds from 2 mm to 3 mm had little effect on the separation between wildtype and 
knockout mice, however, decreasing the age of the mice from 12 weeks to 8 weeks 
provided improved separation in wound healing. The OND hydrogel delivery of CAR-Fc 
to CAR null mice was repeated with 8 week old mice. In addition, a 4th group of mice were 
added to the experiment in order to observe the effects of CAR-Fc applied in solution to 
CAR-/- wounds. There was a modest improvement in separation between knockout and 
wildtype mice, however, CAR-Fc delivered from hydrogels to CAR-/- mice did not 
improve wound healing rates (Figure 19). Although interestingly, CAR-Fc that was 
delivered in solution to CAR-/- mice did improve wound healing to rates similar to 
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wildtype mice. This suggests that CAR-Fc is upregulated very early on after wounding and 




Figure 18. Wound closure in CAR-/- mice treated with CAR-Fc from OND hydrogel 2D. 































Figure 19. Wound closure in CAR-/- mice treated with CAR-Fc from OND hydrogel 2D 
or CAR-Fc from solution. Untreated wildtype and CAR-/- mice were used as controls.  
 
 
3.2.3 Delivery of ICAM-1-Fc 
Although controlled and extended delivery of CAR-Fc was not able to improve 
wound healing in CAR-/- mice, another protein of interest, ICAM-1, was found to promote 
wound healing under our controlled delivery conditions. The release timeline of ICAM-1-
Fc from OND hydrogel 2D was expected to be similar to the BSA and CAR release studies. 
However, to confirm that ICAM-1could still be retained in OND hydrogels the protein was 
labeled with Alexa Fluor 488 and its retention was monitored by fluorescent microscopy. 
At 5 hours ICAM-1 that was delivered in hydrogels could still be detected within the wound 
bed whereas ICAM-1 delivered in solution could no longer be seen in or near the wound 
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both BSA and CAR-Fc. Consequently, further experiments were carried out with the same 
OND hydrogel delivery system as the previous experiments. 
 
 
Figure 20. Fluorescent microscopy images of mouse wound beds collected at different 
times. Mice were given either AF488 labeled ICAM-1-Fc in hydrogel 2D or in buffer. The 
blue color is DAPI stain and the green color is AF488 labeled ICAM-1-Fc. 
 
 
To assess the effectiveness of ICAM-1-Fc delivery from OND hydrogels to 
wounds, hydrogels were applied to ICAM-1 null mice and the rate of wound closure was 
monitored. Results of hydrogel delivery of ICAM-1-Fc to ICAM-1 knockout mice were 
compared against the following three groups: wildtype mice that were treated with empty 
hydrogels, knockout mice that were treated with buffer, and knockout mice that were 
treated with ICAM-1-Fc in solution. Knockout mice that were treated with just buffer 
showed delays in wound healing when compared to wildtype mice. Unlike the CAR-Fc 










improvement in wound healing when compared to knockout mice with just buffer. Finally, 
OND hydrogel delivery of ICAM-1-Fc to ICAM-1 knockout mice successfully improved 
wound healing to rates seen with wildtype mice (Figure 21).  
 
 
Figure 21. Wound closure in ICAM-1-/- mice treated with ICAM-1-Fc from OND 
hydrogel 2D or ICAM-1-Fc from solution. Untreated wildtype and ICAM-1-/- mice were 




We were interested in applying our OND hydrogels to further clinical applications 
and looked towards aged mice, which often have delayed healing due to dysregulated 
expression of ICAM-1 following wounding.37 OND-hydrogels 2D with either ICAM-1-Fc 
or buffer were applied to aged mice and the rate of wound closure was monitored. Mice 
treated with ICAM-1 from OND-hydrogels showed faster wound healing when compared 
to mice that were given the control gel. This difference in wound healing is especially 
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apparent by days 5 and 6 (Figure 22). Collectively, controlled and extended delivery of 




Figure 22. Wound closure in aged mice treated with ICAM-1-Fc from OND hydrogel 2D. 




Oxanorbornadiene hydrogels were successfully applied to in vivo models seeking 
to improve chronic wound healing rates. Hydrogel materials were able to retain dye labeled 
BSA within wound beds and release all cargo at the expected, programmed rates. In 
addition, hydrogel materials 2D were found to be non-toxic to surrounding cells (2.4.5.2 
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While OND hydrogels were able to deliver CAR-Fc to CAR null mice in the 
programmed timeframe, it was found that extended delivery of CAR was not beneficial to 
wound healing in this model as the costimulatory molecule was upregulated very quickly 
after wounding. Although controlled delivery of CAR was not beneficial, OND hydrogel 
delivery of ICAM-1-Fc to ICAM-1 null mice was successfully able to improve wound 
healing rates. These results were reproduced in an aged mice model, showing that delivery 
of ICAM-1-Fc to aged mice could improve wound healing, which is significant since much 
of the chronic wound population is elderly. Collectively, the utility of OND hydrogels was 
demonstrated in in vivo models. It is expected that OND hydrogels could be just as useful 
in applications that require longer delivery timeframes.  
2.4 Experimental 
2.4.1 In vivo wounding strategies 
Isoflurane was administered to mice with a precision vaporizer and a regulated 
oxygen flow. The incision site was shaved and cleaned with topical disinfectant. Excision 
wounds were then made on the backs of mice (2-6 wounds/mouse) with a 2 mm biopsy 
instrument. Gels or PBS (control) were then applied directly to the wound beds and then 
were covered with bandages.  
2.4.2 In vivo delivery of Texas Red labeled BSA   
2.4.2.1 Texas Red labeling of bovine serum albumin 
 1 mL of BSA (5 mg/ml) was incubated with NHS-Texas Red (122.8 µg, 2 equiv.) 
overnight at room temperature. BSA was separated from excess dye by a PD-10 desalting 
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column gravity protocol published by the manufacturer. BSA-TxRed was concentrated to 
1 mL by centrifugation in 10 kDa MWCO for 8 minutes at 4000x g followed by buffer 
exchange with 0.001 M potassium phosphate buffer. Protein concentration was measured 
by Bradford assay with BSA calibration standards. To obtain BSA-TxRed with a free thiol 
the sample was diluted to 2 mg/mL and treated with 10 mM DTT at 37°C for 1 hour. BSA-
TxRed was then purified by PD-10 desalting column with the gravity protocol published 
by the manufacturer. The sample was concentrated to 1 mL by centrifugation in 10 kDa 
MWCO for 8 minutes at 4000x g and protein concentration was measured by Bradford 
assay with BSA calibration standards.  
2.4.2.2 Delivery of Texas Red labeled BSA 
10 µg BSA-TxRed was delivered in either hydrogel or in PBS directly on mouse 
wound beds. To make the hydrogels, OND material and thiol material were dissolved 
separately in 2 mg/mL BSA-TxRed solution in 0.001 M potassium phosphate buffer. The 
vials were placed on ice and then combined, mixed, and transferred directly to mouse 
wound beds. For each delivery method (hydrogel or buffer) there were at least two time 
points with 5 mice each with each mouse having at least 2 wounds. At selected timepoints 
the mice were sacrificed, and entire wounds were excised, stained with DAPI, and viewed 
by fluorescence microscopy to detect retention of BSA-TxRed in the wound bed. Delivery 
of Texas Red labeled BSA was used to screen various OND hydrogels to determine which 
gel system to use for further delivery studies. It was found that 10 wt% OND-PEG gels had 




2.4.3 In vivo delivery of CAR-Fc from OND hydrogels 
10 µg CAR-Fc was delivered to either CAR knockout mice or wildtype mice in 
either hydrogel or potassium phosphate buffer. To make the hydrogels, PEG-OND material 
and dextran-thiol material were dissolved separately in CAR-Fc solution in 0.001 M 
potassium phosphate buffer. The vials were placed on ice and then combined, mixed, and 
transferred directly to mouse wound beds. Effects of hydrogel delivery of CAR-Fc to CAR 
knockout mice were compared against the following three groups: wildtype mice that were 
treated with empty hydrogels (no CAR-Fc), knockout mice that were treated with buffer, 
and knockout mice that were treated with CAR-Fc in solution. Each group had 3 mice with 
2 wounds per mouse for each timepoint. Wound healing was assessed by rate of wound 
closure. 
2.4.4 In vivo delivery of ICAM-1-Fc from OND hydrogels 
10 µg ICAM-1-Fc was delivered to either I-CAM-1 knockout mice or wildtype 
mice in either hydrogel or potassium phosphate buffer. To make the hydrogels, PEG-OND 
material and dextran-thiol material were dissolved separately in ICAM-1-Fc solution in 
0.001 M potassium phosphate buffer. The vials were placed on ice and then combined, 
mixed, and transferred directly to mouse wound beds. Effects of hydrogel delivery of 
ICAM-1-Fc to ICAM-1 knockout mice were compared against the following three groups: 
wildtype mice that were treated with empty hydrogels (no ICAM-1-Fc), knockout mice 
that were treated with buffer, and knockout mice that were treated with ICAM-1-Fc in 
solution. Each group had 3 mice with 2 wound per mouse for each timepoint. Wound 
healing was measured by the undermentioned assays. 
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2.4.5 Wound healing assays 
2.4.5.1 Determination of the rate of wound closure  
For each timepoint, wounds were photographed and the diameter of at least 3 wounds were 
measured three times. Statistical significance was determined by an unpaired 2-tailed 
Student t-test. 
2.4.5.2 Analysis of cell viability post hydrogel treatment 
Toxicity of hydrogel materials were assessed by 7-Aminoactinomycin D viability stain and 
flow cytometry of dendritic epidermal T cells 24 hours following wounding. Percent 
apoptotic cells were determined by Annexin-V staining in epidermal sheets following 
wounding. 5 µL of either hydrogel material or PBS were delivered directly on mouse 
wound beds. There were 4 mice in each group with each mouse having four wounds. 
 
 
Figure 23. Cell viability post hydrogel 2D treatment. (A) dead cells. (B) dying cells.   
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Hydrogel delivery systems have greatly improved over the past few decades and 
are now able to achieve controlled and sustained delivery of therapeutics over longer 
timeframes. However, many of these delivery systems are not easily tunable to achieve 
different release profiles, which limits their potential applications. Thus, materials that are 
able to be broadly useful for a variety of applications from drug delivery to tissue 
engineering remain an unmet need in the field of hydrogel systems. Oxanorbornadiene 
reagents have been shown to have highly tunable fragmentation rates from hours to months, 
making them promising as cleavable linkages in degradable hydrogels. This thesis furthers 
the scope of oxanorbornadiene hydrogels in therapeutic applications.   
 In chapter 2 the effects of different crosslinking compositions on hydrogel 
properties was explored. In total, 12 different hydrogels were synthesized with 3 different 
ONDs and 4 different crosslinking systems. All hydrogels were fully formed in less than 
20 seconds at physiological pH and had high material incorporation and low swelling 
ratios. It was found that methyl ester OND hydrogels could be tuned to deliver entrained 
cargo over 12 to 66 hours depending on the crosslinking system. As expected, 
trifluoromethyl ONDs had much longer release timelines and were able to deliver entrained 
cargo over 7 to 25 days depending on the crosslinking system. Epoxide gels were non-
degradable and were unable to release entrained cargo, which demonstrated the 
dependence of cargo release on the retro-Diels-Alder reactions of OND linkages.  
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 Chapter 3 examined the translation of OND hydrogels to in vivo experiments 
seeking to promote improved healing in chronic wounds. Hydrogels were easily applied to 
wound beds by separately dissolving OND and thiol material, combining solutions, and 
depositing the hydrogel solution directly onto wounds. Hydrogel materials were found to 
be non-toxic and were able to release cargo into surrounding wound tissue within the 
programmed timeframes. Delivery of CAR-Fc to CAR null mice was able to improve 
wound healing, however, these improvements were not achieved by hydrogel delivery, 
suggesting that extended delivery of the costimulatory molecule is not necessary. In 
contrast, OND hydrogel delivery of ICAM-1-Fc to ICAM-1 null mice was necessary in 
order to successfully improve wound healing rates to what was observed with wildtype 
mice. Lastly, OND hydrogel delivery of ICAM-1-Fc was able to improve wound healing 
rates in aged mice, which is significant since much of the chronic wound population is 
elderly.  
 In the future, we hope to expand the utility of OND hydrogels by investigating them 
in the context of different delivery methods and applications. The implementation of OND 
hydrogels for topical delivery has been demonstrated in this work. We are next interested 
in developing OND hydrogels as injectable depots. There are many advantages to 
injectable depot drug delivery systems including their ability to localize therapeutics, 
reduce off-target effects, and be applied directly to tissues of interest without surgical 
implantation. We believe that OND hydrogels will be amenable to this delivery system due 
to their rapid gelation at physiological pH and temperature. Continuing to investigate OND 
hydrogels will further the goal of realizing simple hydrogel drug delivery systems that can 
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